All Online

1 - 12 of 22 results

Refine

Active filters

Neurology
brain xray
1 CME CREDIT

One in fifty people in the U.S. has an unruptured brain aneurysm, and one ruptures every 18 minutes. Despite low frequency, brain aneurysms are high in mortality, because the lack of a timely diagnosis often leads to death. Complicating matters more, many of the symptoms are associated with other less dangerous conditions, such as influenza or stress. This session will describe the importance of early detection, since brain aneurysms are treatable via proper identification, and will highlight risk factors and populations who are most vulnerable. Faculty will also review treatment options for clinicians to recognize or use in practice.


man with headache pinching at temples
1 CME CREDIT

First Contact - Headache in Primary Care

1.00 CME/MOC
1.00 AANP | 0.25 Pharmacology

Migraine affects 1 in 7 people worldwide and is the second leading cause of all global disability. Primary care practitioners are often the first contact for patients with migraine, yet it can be challenging to distinguish migraine from other headache disorders and remain current on best practices for management. Tune in to this session, developed by the American Headache Society as part of the First Contact – Headache in Primary Care initiative to learn strategies for accurate and timely identification of migraine and review updates to management.


Woman and Brain
2 CME CREDITS

Migraine: A Patient-centered Approach to Diagnosis and Treatment

An Interactive Learning ExperienceThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

2.00 CME

How does your management of patients with migraine compare to the experts? By participating in this six-part educational initiative, which incorporates a comprehensive roundtable faculty discussion, augmented reality, and a patient narrative, you will be able to incorporate key information into your clinical practice immediately.


Tile overview image
1 CME CREDIT

What Primary Care Clinicians Need to Know About Alzheimer’s Disease: Early Diagnosis, Patient-Specific Management, and Care Collaboration

An Interactive Learning Experience From ArcheMedX This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

1.00 CME/MOC
1.00 AANP | 0.33 Pharmacology

What do primary care providers (physicians, nurse practitioners, and physician assistants) need to know about caring for patients with Alzheimer’s disease (AD)? Primary care providers (PCPs) are well positioned to spot the earliest signs of cognitive decline — and patients are more likely to discuss sensitive topics, such as cognitive concerns, with a provider they know and trust. This engaging activity will provide you with the latest information regarding the role of PCPs in early diagnosis of AD, approaches to address racial and ethnic barriers to dementia-related care, and strategies to encourage collaboration among PCPs and AD specialists. Patient-specific management considerations, including the role of recently approved and emerging disease-modifying therapies, will also be addressed. Following completion of this 60-minute educational activity, you will be better equipped to optimize care for your patients with AD.


Tile overview question
0.29 CME CREDIT

Your Questions About Migraine Answered

0.25 CME/MOC
0.29 AANP | 0.10 Pharmacology

In this podcast, Dr. Dawn Buse will address questions about migraine diagnosis and treatment posed by Pri-Med learners during recent programs. Topics will include deciding when imaging is appropriate in the evaluation of headache, distinguishing between migraine and cluster headache, determining which patients would benefit from preventive migraine therapy, considering how long to use a preventive therapy before determining it to be ineffective, managing menstrual migraines, and treating migraine in children and adolescents.


Tile overview image
0.25 CME CREDIT

This podcast will focus on the case of a patient with a long history of periodic migraine attacks whose previously preferred acute medication is now contraindicated because of a recently acquired comorbid condition. Faculty will consider newer medication options for this patient that will take into account his employment requirements and individual preferences, as well as his medical history.


Young woman suffering bad and strong headache
1 CME CREDIT

The entire field of migraine is witnessing a profound and unprecedented transformation with new therapeutic options now available to address serious unmet medical needs and patient burden. The new options range from monoclonal antibodies (mAbs) targeting the CGRP ligand or receptor for migraine prevention, to a selective serotonin agonist, to oral CGRP-targeting agents (gepants) now approved for both preventive and acute treatment. These new advances are creating a vitality and excitement in the field not seen since the advent of triptans more than 2 decades ago.


Doctor talking to elderly patient with a caregiver present
0.53 CME CREDIT

Early Detection and Diagnosis of Alzheimer Disease

An Interactive Learning ExperienceThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.53 AANP

In this AdaptED learning module, learners will engage with the adaptive learning algorithm to explore the assessment and diagnosis of Alzheimer disease (AD). The activity will provide practical guidance for primary care providers on the clinical diagnosis of AD, including cognitive testing. It will also discuss neuroimaging and fluid markers to aid in diagnosis and monitoring of AD, including ongoing research in serum biomarkers that may soon expedite disease recognition. The AdaptED module will provide learners with evidence-based education in a convenient format that facilitates quick application of the material.


Clinician talking to elderly person
0.3 CME CREDIT

Despite the growing prevalence and devastating effects of Alzheimer disease (AD), mild cognitive impairment (MCI) often goes unrecognized in the primary care setting. This brief podcast highlights the need for primary care providers to identify individuals with MCI as early as possible so they can be assessed and, if diagnosed with AD, treated promptly. Expert faculty will explore the manifold benefits of early evaluation, which can include identifying reversible causes of MCI, taking advantage of new effective treatments, and reducing patients’ risk of premature mortality. You’ll walk away from this podcast with strategies to help you earlier identify these patients and, ultimately, maintain their cognitive abilities and quality of life for a longer period.


modern abstract brain image
0.5 CME CREDIT

New and Emerging Therapies for Alzheimer Disease

An Interactive Learning ExperienceThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.50 AANP | 0.50 Pharmacology